![Elena Feinstein](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Elena Feinstein
Director Técnico/Científico/I+D en Quark Pharmaceuticals, Inc. .
Cargos activos de Elena Feinstein
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Quark Pharmaceuticals, Inc.
![]() Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Director Técnico/Científico/I+D | 01/01/1998 | - |
Historial de carrera de Elena Feinstein
Formación de Elena Feinstein.
Moscow University | Doctorate Degree |
Weizmann Institute of Science | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 2 |
Rusia | 2 |
Israel | 2 |
Operativa
Doctorate Degree | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorial
Consumer Services | 3 |
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Quark Pharmaceuticals, Inc.
![]() Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Elena Feinstein
- Experiencia